世界の網膜芽細胞腫治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Retinoblastoma Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5026
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、網膜芽細胞腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（先天性（遺伝性）網膜芽細胞腫、散発性（非遺伝性）網膜芽細胞腫）、用途別市場規模（病院、がん研究所、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・網膜芽細胞腫治療の市場動向
・企業の競争状況、市場シェア
・網膜芽細胞腫治療の種類別市場規模（先天性（遺伝性）網膜芽細胞腫、散発性（非遺伝性）網膜芽細胞腫）
・網膜芽細胞腫治療の用途別市場規模（病院、がん研究所、薬局）
・網膜芽細胞腫治療の北米市場規模2016-2027（アメリカ、カナダ）
・網膜芽細胞腫治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・網膜芽細胞腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・網膜芽細胞腫治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・網膜芽細胞腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Innovation Pharmaceuticals Inc.、Merck & Co.、Novartis、Sheba、UCSF Benioff Children’s Hospital San Francisco、Henry Ford、Mayo Clinic）
・結論

Retinoblastoma is a cancer that starts in the retina, the very back part of the eye.

Market Analysis and Insights: Global Retinoblastoma Treatment Market
The global Retinoblastoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Retinoblastoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Retinoblastoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Retinoblastoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Retinoblastoma Treatment market.

Global Retinoblastoma Treatment Scope and Market Size
Retinoblastoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Retinoblastoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Congenital (Hereditary) Retinoblastoma
Sporadic (Non-Hereditary) Retinoblastoma

Segment by Application
Hospitals
Cancer Institutes
Pharmacies

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Innovation Pharmaceuticals Inc.
Merck & Co.
Novartis
Sheba
UCSF Benioff Children’s Hospital San Francisco
Henry Ford
Mayo Clinic

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinoblastoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Congenital (Hereditary) Retinoblastoma
1.2.3 Sporadic (Non-Hereditary) Retinoblastoma
1.3 Market by Application
1.3.1 Global Retinoblastoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Cancer Institutes
1.3.4 Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Retinoblastoma Treatment Market Perspective (2016-2027)
2.2 Retinoblastoma Treatment Growth Trends by Regions
2.2.1 Retinoblastoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Retinoblastoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Retinoblastoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Retinoblastoma Treatment Industry Dynamic
2.3.1 Retinoblastoma Treatment Market Trends
2.3.2 Retinoblastoma Treatment Market Drivers
2.3.3 Retinoblastoma Treatment Market Challenges
2.3.4 Retinoblastoma Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Retinoblastoma Treatment Players by Revenue
3.1.1 Global Top Retinoblastoma Treatment Players by Revenue (2016-2021)
3.1.2 Global Retinoblastoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Retinoblastoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Retinoblastoma Treatment Revenue
3.4 Global Retinoblastoma Treatment Market Concentration Ratio
3.4.1 Global Retinoblastoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinoblastoma Treatment Revenue in 2020
3.5 Retinoblastoma Treatment Key Players Head office and Area Served
3.6 Key Players Retinoblastoma Treatment Product Solution and Service
3.7 Date of Enter into Retinoblastoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Retinoblastoma Treatment Breakdown Data by Type
4.1 Global Retinoblastoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Retinoblastoma Treatment Forecasted Market Size by Type (2022-2027)

5 Retinoblastoma Treatment Breakdown Data by Application
5.1 Global Retinoblastoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Retinoblastoma Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Retinoblastoma Treatment Market Size (2016-2027)
6.2 North America Retinoblastoma Treatment Market Size by Type
6.2.1 North America Retinoblastoma Treatment Market Size by Type (2016-2021)
6.2.2 North America Retinoblastoma Treatment Market Size by Type (2022-2027)
6.2.3 North America Retinoblastoma Treatment Market Size by Type (2016-2027)
6.3 North America Retinoblastoma Treatment Market Size by Application
6.3.1 North America Retinoblastoma Treatment Market Size by Application (2016-2021)
6.3.2 North America Retinoblastoma Treatment Market Size by Application (2022-2027)
6.3.3 North America Retinoblastoma Treatment Market Size by Application (2016-2027)
6.4 North America Retinoblastoma Treatment Market Size by Country
6.4.1 North America Retinoblastoma Treatment Market Size by Country (2016-2021)
6.4.2 North America Retinoblastoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Retinoblastoma Treatment Market Size (2016-2027)
7.2 Europe Retinoblastoma Treatment Market Size by Type
7.2.1 Europe Retinoblastoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Retinoblastoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Retinoblastoma Treatment Market Size by Type (2016-2027)
7.3 Europe Retinoblastoma Treatment Market Size by Application
7.3.1 Europe Retinoblastoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Retinoblastoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Retinoblastoma Treatment Market Size by Application (2016-2027)
7.4 Europe Retinoblastoma Treatment Market Size by Country
7.4.1 Europe Retinoblastoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Retinoblastoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Retinoblastoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Retinoblastoma Treatment Market Size by Type
8.2.1 Asia-Pacific Retinoblastoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Retinoblastoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Retinoblastoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Retinoblastoma Treatment Market Size by Application
8.3.1 Asia-Pacific Retinoblastoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Retinoblastoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Retinoblastoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Retinoblastoma Treatment Market Size by Region
8.4.1 Asia-Pacific Retinoblastoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Retinoblastoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Retinoblastoma Treatment Market Size (2016-2027)
9.2 Latin America Retinoblastoma Treatment Market Size by Type
9.2.1 Latin America Retinoblastoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Retinoblastoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Retinoblastoma Treatment Market Size by Type (2016-2027)
9.3 Latin America Retinoblastoma Treatment Market Size by Application
9.3.1 Latin America Retinoblastoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Retinoblastoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Retinoblastoma Treatment Market Size by Application (2016-2027)
9.4 Latin America Retinoblastoma Treatment Market Size by Country
9.4.1 Latin America Retinoblastoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Retinoblastoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Retinoblastoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Retinoblastoma Treatment Market Size by Type
10.2.1 Middle East & Africa Retinoblastoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Retinoblastoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Retinoblastoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Retinoblastoma Treatment Market Size by Application
10.3.1 Middle East & Africa Retinoblastoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Retinoblastoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Retinoblastoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Retinoblastoma Treatment Market Size by Country
10.4.1 Middle East & Africa Retinoblastoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Retinoblastoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Innovation Pharmaceuticals Inc.
11.1.1 Innovation Pharmaceuticals Inc. Company Details
11.1.2 Innovation Pharmaceuticals Inc. Business Overview
11.1.3 Innovation Pharmaceuticals Inc. Retinoblastoma Treatment Introduction
11.1.4 Innovation Pharmaceuticals Inc. Revenue in Retinoblastoma Treatment Business (2016-2021)
11.1.5 Innovation Pharmaceuticals Inc. Recent Development
11.2 Merck & Co.
11.2.1 Merck & Co. Company Details
11.2.2 Merck & Co. Business Overview
11.2.3 Merck & Co. Retinoblastoma Treatment Introduction
11.2.4 Merck & Co. Revenue in Retinoblastoma Treatment Business (2016-2021)
11.2.5 Merck & Co. Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Retinoblastoma Treatment Introduction
11.3.4 Novartis Revenue in Retinoblastoma Treatment Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Sheba
11.4.1 Sheba Company Details
11.4.2 Sheba Business Overview
11.4.3 Sheba Retinoblastoma Treatment Introduction
11.4.4 Sheba Revenue in Retinoblastoma Treatment Business (2016-2021)
11.4.5 Sheba Recent Development
11.5 UCSF Benioff Children’s Hospital San Francisco
11.5.1 UCSF Benioff Children’s Hospital San Francisco Company Details
11.5.2 UCSF Benioff Children’s Hospital San Francisco Business Overview
11.5.3 UCSF Benioff Children’s Hospital San Francisco Retinoblastoma Treatment Introduction
11.5.4 UCSF Benioff Children’s Hospital San Francisco Revenue in Retinoblastoma Treatment Business (2016-2021)
11.5.5 UCSF Benioff Children’s Hospital San Francisco Recent Development
11.6 Henry Ford
11.6.1 Henry Ford Company Details
11.6.2 Henry Ford Business Overview
11.6.3 Henry Ford Retinoblastoma Treatment Introduction
11.6.4 Henry Ford Revenue in Retinoblastoma Treatment Business (2016-2021)
11.6.5 Henry Ford Recent Development
11.7 Mayo Clinic
11.7.1 Mayo Clinic Company Details
11.7.2 Mayo Clinic Business Overview
11.7.3 Mayo Clinic Retinoblastoma Treatment Introduction
11.7.4 Mayo Clinic Revenue in Retinoblastoma Treatment Business (2016-2021)
11.7.5 Mayo Clinic Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Retinoblastoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Congenital (Hereditary) Retinoblastoma
Table 3. Key Players of Sporadic (Non-Hereditary) Retinoblastoma
Table 4. Global Retinoblastoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Retinoblastoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Retinoblastoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Retinoblastoma Treatment Market Share by Regions (2016-2021)
Table 8. Global Retinoblastoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Retinoblastoma Treatment Market Share by Regions (2022-2027)
Table 10. Retinoblastoma Treatment Market Trends
Table 11. Retinoblastoma Treatment Market Drivers
Table 12. Retinoblastoma Treatment Market Challenges
Table 13. Retinoblastoma Treatment Market Restraints
Table 14. Global Retinoblastoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Retinoblastoma Treatment Market Share by Players (2016-2021)
Table 16. Global Top Retinoblastoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinoblastoma Treatment as of 2020)
Table 17. Ranking of Global Top Retinoblastoma Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Retinoblastoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Retinoblastoma Treatment Product Solution and Service
Table 21. Date of Enter into Retinoblastoma Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Retinoblastoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Retinoblastoma Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Retinoblastoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Retinoblastoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Retinoblastoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Retinoblastoma Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Retinoblastoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Retinoblastoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Retinoblastoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Retinoblastoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Retinoblastoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Retinoblastoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Retinoblastoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Retinoblastoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Retinoblastoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Retinoblastoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Retinoblastoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Retinoblastoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Retinoblastoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Retinoblastoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Retinoblastoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Retinoblastoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Retinoblastoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Retinoblastoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Retinoblastoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Retinoblastoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Retinoblastoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Retinoblastoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Retinoblastoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Retinoblastoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Retinoblastoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Retinoblastoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Retinoblastoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Retinoblastoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Retinoblastoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Retinoblastoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Retinoblastoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Retinoblastoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Innovation Pharmaceuticals Inc. Company Details
Table 62. Innovation Pharmaceuticals Inc. Business Overview
Table 63. Innovation Pharmaceuticals Inc. Retinoblastoma Treatment Product
Table 64. Innovation Pharmaceuticals Inc. Revenue in Retinoblastoma Treatment Business (2016-2021) & (US$ Million)
Table 65. Innovation Pharmaceuticals Inc. Recent Development
Table 66. Merck & Co. Company Details
Table 67. Merck & Co. Business Overview
Table 68. Merck & Co. Retinoblastoma Treatment Product
Table 69. Merck & Co. Revenue in Retinoblastoma Treatment Business (2016-2021) & (US$ Million)
Table 70. Merck & Co. Recent Development
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Retinoblastoma Treatment Product
Table 74. Novartis Revenue in Retinoblastoma Treatment Business (2016-2021) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Sheba Company Details
Table 77. Sheba Business Overview
Table 78. Sheba Retinoblastoma Treatment Product
Table 79. Sheba Revenue in Retinoblastoma Treatment Business (2016-2021) & (US$ Million)
Table 80. Sheba Recent Development
Table 81. UCSF Benioff Children’s Hospital San Francisco Company Details
Table 82. UCSF Benioff Children’s Hospital San Francisco Business Overview
Table 83. UCSF Benioff Children’s Hospital San Francisco Retinoblastoma Treatment Product
Table 84. UCSF Benioff Children’s Hospital San Francisco Revenue in Retinoblastoma Treatment Business (2016-2021) & (US$ Million)
Table 85. UCSF Benioff Children’s Hospital San Francisco Recent Development
Table 86. Henry Ford Company Details
Table 87. Henry Ford Business Overview
Table 88. Henry Ford Retinoblastoma Treatment Product
Table 89. Henry Ford Revenue in Retinoblastoma Treatment Business (2016-2021) & (US$ Million)
Table 90. Henry Ford Recent Development
Table 91. Mayo Clinic Company Details
Table 92. Mayo Clinic Business Overview
Table 93. Mayo Clinic Retinoblastoma Treatment Product
Table 94. Mayo Clinic Revenue in Retinoblastoma Treatment Business (2016-2021) & (US$ Million)
Table 95. Mayo Clinic Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinoblastoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. Congenital (Hereditary) Retinoblastoma Features
Figure 3. Sporadic (Non-Hereditary) Retinoblastoma Features
Figure 4. Global Retinoblastoma Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Cancer Institutes Case Studies
Figure 7. Pharmacies Case Studies
Figure 8. Retinoblastoma Treatment Report Years Considered
Figure 9. Global Retinoblastoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Retinoblastoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Retinoblastoma Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Retinoblastoma Treatment Market Share by Regions (2022-2027)
Figure 13. Global Retinoblastoma Treatment Market Share by Players in 2020
Figure 14. Global Top Retinoblastoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinoblastoma Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Retinoblastoma Treatment Revenue in 2020
Figure 16. Global Retinoblastoma Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Retinoblastoma Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Retinoblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Retinoblastoma Treatment Market Share by Type (2016-2027)
Figure 20. North America Retinoblastoma Treatment Market Share by Application (2016-2027)
Figure 21. North America Retinoblastoma Treatment Market Share by Country (2016-2027)
Figure 22. United States Retinoblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Retinoblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Retinoblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Retinoblastoma Treatment Market Share by Type (2016-2027)
Figure 26. Europe Retinoblastoma Treatment Market Share by Application (2016-2027)
Figure 27. Europe Retinoblastoma Treatment Market Share by Country (2016-2027)
Figure 28. Germany Retinoblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Retinoblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Retinoblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Retinoblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Retinoblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Retinoblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Retinoblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Retinoblastoma Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Retinoblastoma Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Retinoblastoma Treatment Market Share by Region (2016-2027)
Figure 38. China Retinoblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Retinoblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Retinoblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Retinoblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Retinoblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Retinoblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Retinoblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Retinoblastoma Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Retinoblastoma Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Retinoblastoma Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Retinoblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Retinoblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Retinoblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Retinoblastoma Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Retinoblastoma Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Retinoblastoma Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Retinoblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Retinoblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Retinoblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Innovation Pharmaceuticals Inc. Revenue Growth Rate in Retinoblastoma Treatment Business (2016-2021)
Figure 58. Merck & Co. Revenue Growth Rate in Retinoblastoma Treatment Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Retinoblastoma Treatment Business (2016-2021)
Figure 60. Sheba Revenue Growth Rate in Retinoblastoma Treatment Business (2016-2021)
Figure 61. UCSF Benioff Children’s Hospital San Francisco Revenue Growth Rate in Retinoblastoma Treatment Business (2016-2021)
Figure 62. Henry Ford Revenue Growth Rate in Retinoblastoma Treatment Business (2016-2021)
Figure 63. Mayo Clinic Revenue Growth Rate in Retinoblastoma Treatment Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

以下、関連資料のご紹介

世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年）

Global Acquired hemophilia A Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0029 2021年4月 97Pages
QYResearch社発行の本調査資料では、後天性血友病A治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（200IU、250IU）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年）

Global Swedish Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5520 2021年4月 99Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年）

Global Acute Intermittent Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0060 2021年4月 92Pages
QYResearch社発行の本調査資料では、急性間欠性ポルフィリン症（AIP）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界の軟骨無形成症治療市場規模・現状・予測（2021年-2027年）

Global Achondroplasia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0013 2021年4月 92Pages
QYResearch社発行の本調査資料では、軟骨無形成症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（RBM-007、TA-46、B-701、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0096 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界のMSD治療市場規模・現状・予測（2021年-2027年）

Global MSD Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3939 2021年4月 91Pages
QYResearch社発行の本調査資料では、MSD治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジ...

世界の高カルシウム血症治療市場規模・現状・予測（2021年-2027年）

Global Hypercalcemia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2989 2021年4月 93Pages
QYResearch社発行の本調査資料では、高カルシウム血症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ビスフォスフォネート、糖質コルチコイド、カルシウム模倣薬）、用途別市場規模（軽度高カルシウム血症、中度高カルシウム血症、重度高カルシ...

世界のアフリカトリパノソーマ症治療市場規模・現状・予測（2021年-2027年）

Global African Trypanosomiasis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0157 2021年4月 95Pages
QYResearch社発行の本調査資料では、アフリカトリパノソーマ症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（MS-08、CBL-0137、AN-5568、GNF-6702、その他）、用途別市場規模（研究センター、病院、クリニック、そ...

世界の神経芽細胞腫治療市場規模・現状・予測（2021年-2027年）

Global Neuroblastoma Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4085 2021年4月 90Pages
QYResearch社発行の本調査資料では、神経芽細胞腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（併用化学療法、モノクローナル抗体療法、ワクチン療法、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ...

世界のクラッベ病治療市場規模・現状・予測（2021年-2027年）

Global Krabbe Disease Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3334 2021年4月 92Pages
QYResearch社発行の本調査資料では、クラッベ病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗けいれん薬、筋弛緩薬、HSCT（造血幹細胞移植）、その他）、用途別市場規模（病院、ASC）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界の遺伝性血管浮腫治療市場 2021：企業別、地域別、種類・用途別 The Hereditary Angioedema Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
世界の遺伝性がん検査市場規模・現状・予測（2021年-2027年） Hereditary cancer testing is a process of identifying an inherited gene mutation that increases the risk of cancer development. It mainly includes predictive genetic testing and clinical DNA sequencing, in predictive genetic testing, patient’s family history is analyzed for any inherited mutation fr…
世界の遺伝性がん検査市場規模・現状・予測（2021年-2027年） Hereditary cancer testing is a process of identifying an inherited gene mutation that increases the risk of cancer development. It mainly includes predictive genetic testing and clinical DNA sequencing, in predictive genetic testing, patient’s family history is analyzed for any inherited mutation fr…
世界の遺伝性血管性浮腫薬市場 2021：企業別、地域別、種類・用途別 The Hereditary Angioedema Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
世界の甲状腺がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Thyroid Cancer Treatment Market The global Thyroid Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …